|
| 1. Introduction |
For centuries, women everywhere in the world have
felt entitled to terminate unwanted or mistimed
pregnancies, and used whatever means were known and
available to them to do so. The development of modern
medical technology has now made it possible for women to
terminate a pregnancy surgically without jeopardising
their lives and their health. 
An alternative to surgical abortion, a combination of
two drugs (“abortion pills”) which induce abortion was
first licensed in France in 1988. One of the two drugs,
Mifepristone, is now (2005) licensed in 35 countries . More than 22 million
women in
China
and about four
million in the rest of the world have used the method to
terminate a pregnancy, and have found it safe and
effective [1].
The second drug, Misoprostol, is registered for the
prevention of gastric ulcers induced by the use of
non-steroidal anti-inflammatory drugs in over 80
countries [2]. Thus, misoprostol is
available in countries where mifepristone is not yet
registered.
In many countries, including those with legal
restrictions or limited access to abortion, one or both
of these drugs are available across the counter in
pharmacies. Recent studies have shown that many women,
especially in countries where access to abortion
services is limited, need more information about the
abortion pills. This fact sheet, presented in a
question-and-answer format, answers in simple terms
questions that women usually ask about ‘abortion pills’.
It aims to inform women about drugs that can safely and
effectively be used to bring about an abortion, so as to
enable them to make informed decisions about termination
of pregnancy. In countries where abortion is legally
available, it is safest if women use these drugs under
the guidance of a health provider, if possible.
|
|
| 2. What is medical
abortion? |
Medical abortion is the termination of pregnancy
through the use of a drug or a combination of drugs.
|
|
| BOX 1: Emergency
contraception is not the same as medical abortion |
Pills used for emergency
contraception (EC), also known as the ‘morning-after’
pill, are used to prevent pregnancy through an effect on
ovulation but do not disrupt pregnancy. Medical
abortion, on the other hand, induces abortion in women
who are already pregnant.
EC pills consist of a progesterone-like hormone in
much higher doses than in oral contraceptive pills. They
are for use by a woman if:
• |
neither she nor her partner has used a method of
contraception at their most recent intercourse OR |
• |
they fear that the contraceptive used has failed
(e.g. the condom broke or slipped off in the vagina) |
• |
sexual intercourse was within the past 120 hours. |
It is advisable to take EC pills as soon as possible
after unprotected sexual intercourse. The sooner they
are taken, the more effective they are. If not taken
within 120 hours, then EC is not likely to prevent
pregnancy. EC pills are less effective in preventing
pregnancy and have more side effects than most forms of
regular contraception. After use the EC pills do not
protect against further acts of unprotected
intercourse.They are therefore not considered suitable
for routine use.
(For more information on emergency contraception,
refer to http://www.cecinfo.org/ )
|
|
| 3. What drugs are
used for medical abortion? |
Mifepristone and
misoprostol
The most commonly used combination of drugs for
medical abortion is
• |
mifepristone, an anti-progestogen drug,
taken first, and |
• |
misoprostol, a prostaglandin drug , taken
24-48 hours later |
Mifepristone causes the thinning of the uterine
lining and softening of the cervix and combined with
misoprostol causes strong contractions in the
uterus. Together, the drugs cause the products of
pregnancy to be expelled. The result is very much like a
spontaneous abortion or miscarriage [3].
Mifepristone is commonly available as
“Mifiprex”, “Mifegyne” or “Mifegest”. It is sold under
several other brand names in India and China.
Misoprostol is commonly available under the
names Cytotec, Oxaprost or Cytoprost.
Misoprostol
alone
In some settings, the prostaglandin misoprostol alone
is used for medical abortion. This is often because
mifepristone is not available or not
affordable. When misoprostol alone is used, it
causes uterine contractions, softening of the cervix and
the products of pregnancy are expelled. But without
mifepristone pre-treatment, a higher dose of misoprostol
is needed. The abortion process can take longer and be
more painful, with more side effects [3]. The likelihood of a
complete abortion is also somewhat lower than in
combination with mifepristone. But misoprostol remains a
safer option than other dangerous and invasive methods
of abortion that women resort to when safe abortion
services are not available.
Methotrexate and
misoprostol
In countries where mifepristone is not
available, methotrexate has been used in combination
with misoprostol. However, methotrexate is not
recommended by the World Health Organization (WHO) for
inducing abortion, because of concerns that it may
increase the risk of fetal malformation in a continuing
pregnancy [4]. It also involves a
more prolonged abortion process.
|
|
| 4. When during a
woman's pregnancy can medical abortion be used? |
Medical abortion can be used from very early in
pregnancy up to 24 weeks counting from the first day of
the last menstrual period (LMP) [4].
However, the dosage and regimens change at 9 weeks, for
9 - 13 weeks and for 13 - 24 weeks of pregnancy [5].
|
|
| 5. Are there any
women who cannot use medical abortion? |
It is advisable for a woman not to use the
mifepristone/misoprostol regimen for medical abortion if
she has any one of the following health conditions [6]:
• |
Her health provider suspects or has confirmed that
she has an ectopic pregnancy (see BOX 2). |
• |
She has an allergy to mifepristone . |
• |
She has an allergy to misoprostol . |
• |
She has a disease or condition affecting blood's
ability to clot. |
• |
She is taking drugs for thinning the blood. |
• |
She is taking certain steroid drugs. If she is
taking drugs orally or as injections for treating
chronic arthritis, asthma and other allergic
conditions, she should check to see if these are (or
contain) corticosteroids. If in doubt, her health
provider may be consulted. |
• |
She suffers from chronic failure of adrenal
glands. Adrenal glands are small, triangular glands
located on top of the kidneys and produce a variety of
hormones including adrenaline, essential to help the
body cope with stress. |
• |
She has inherited porphyries, which is an uncommon
disorder of certain enzymes responsible for the
formation of the iron-containing pigments in
proteins. |
None of the above conditions, apart from allergy to
misoprostol, applies to the use of misoprostol
alone.
If a woman has an IUD in place in the uterus, this
should be removed prior to use of medical abortion with
mifepristone/misoprostol combination or with misoprostol
alone.
Women with mild to moderate anaemia (haemoglobin
levels between 9 and 12 gm/dl) can use medical abortion.
However, it may be beneficial for women with mild to
moderate anaemia to take iron pills when using medical
or surgical abortion.
|
|
| BOX 2: Ectopic
pregnancy |
An ectopic pregnancy is
a condition where a fertilized egg settles and grows in
any location other than the inner lining of the uterus.
The vast majority of ectopic pregnancies occur in the
fallopian tube (95%); however, they can occur in other
locations, such as the ovary, cervix or abdominal cavity
[7].
Ectopic pregnancy can
be asymptomatic in the initial stages. Symptoms of an
ectopic pregnancy can often be vague, and include
vaginal bleeding, abdominal or pelvic pain (usually
stronger on one side), shoulder pain, weakness or
dizziness. These symptoms can also occur in other
conditions such as ovarian cysts, miscarriages, or even
in normal pregnancy.
Occasionally, the
doctor may feel a tender mass during the
pelvic examination. If an
ectopic pregnancy is suspected, beta hCG blood tests,
and ultrasound can be used to help confirm the diagnosis
[7].
|
|
| 6. Can a woman use a
medical abortion if she is breastfeeding? |
There is some evidence that mifepristone is
excreted into breastmilk but little evidence regarding
any effect on the adrenal function of the infant. The
evidence that is available suggests that the amounts of
mifepristone ingested by the infant are unlikely to
cause harm [8].
Small amounts of
misoprostol enter breastmilk soon after administration,
but it is not known whether this could have any effect
on the infant. As misoprostol levels decline rapidly, it
has been recommended that misoprostol should be taken
immediately after a feed and the next feed given after
four hours in case of oral administration of misoprostol
and somewhat later after vaginal administration [9].
However, if a woman is worried that the
drugs may be excreted in the breastmilk, she may discard
her milk for 24 hours following the use of
mifepristone/misoprostol or misoprostol alone.
|
|
| 7. Is medical
abortion safe for women who are HIV positive? |
There is no reason why HIV positive women
cannot use medical abortion. HIV positive women may be
at higher risk of reproductive tract infections from
retained products of conception, but this may occur with
medical or surgical abortion.
They may also be at risk for anaemia,
especially if they have malaria or are taking certain
antiretrovirals (ARVs) and iron pills may be prescribed.
The small proportion of women who develop heavy bleeding
need to be treated promptly to avoid serious
consequences [10].
|
|
| 8. Can adolescents
use medical abortion? |
There is no medical reason why medical abortion
may be unsuitable for adolescents. Medical abortion is
more painful for anyone who has never been pregnant, and
this may mean that young nulliparous women may need more
pain medication than women who have previously given
birth.
The availability of medical abortion can be
especially helpful for unmarried adolescents and other
young women who do not have access to safe surgical
abortions in many countries.
|
|
| 9. Can a woman use a
medical abortion if she has a reproductive tract
infection? |
A woman may be aware that she has an infection
of the reproductive tract (RTI) because she is
undergoing treatment for it. Or, she may suspect she has
an RTI because of the symptoms she is experiencing, such
as foul-smelling white or yellow/green discharge,
itching or sores in the genital area, or frequent
urination with pricking pain. Treatment should not be
delayed as untreated infection can have serious health
consequences, including infertility.
During a woman’s first clinic visit for medical
abortion, the health provider is required to take a
detailed history and give a thorough physical
examination, including pelvic examination. If an RTI is
suspected, a laboratory test may be prescribed to
confirm if the woman has a reproductive tract infection.
If a woman has an RTI, then she will be treated
for the infection alongside use of medical abortion. The
same is true when surgical abortion is carried out.
There is no reason to wait for RTI treatment to be
completed before either medical or surgical
abortion.
|
|
| 10. Why do women
choose medical abortion? |
Women choose medical abortion because of its
following features [11], [12]:
• |
belief that it was safer
|
• |
more natural |
• |
no surgery and/or anaesthesia |
• |
one or both drugs may be taken at
home |
• |
can be used in the early stages of
pregnancy |
• |
easier and simpler |
“I liked
the tablets. See, I did not need to stay in the
hospital. With curetting I would have spent two
days there. I told my mother-in-law I was going to
the market. I did not abort at the hospital
although I waited for 3 hours. I was scared, would
mother-in-law come to know? How many days I bled…I
was going to the toilet every hour to check. See,
we don’t have our own toilet. I felt embarrassed.
But it happened when she was out. A little pain
was there but that much is to be tolerated.
Whatever you would have done, pain is always
there. Everything has turned out well. I am very
happy now. I will definitely use this method
again. (Woman from India) [13]
“ ..Being outside of a doctor’s office makes
you feel more in control, like you are not under
somebody’s command. That this is my body, I’m in
charge. I think actually the fact that you insert
(misoprostol) yourself is a feeling like….this is
my choice..my decision. There’s so much more power
in it. (Woman from United States) [14]. |
|
|
| 11. How does a woman
confirm that she is pregnant? |
Pregnancy can be confirmed with a pregnancy
test. There are two types of pregnancy tests, blood and
urine tests. Both tests look for a special hormone, human chorionic gonodotrophine (hCG) that is
only present in the blood and urine when a woman is
pregnant. The urine test may be performed at home using
a pregnancy test kit, available from pharmacies, while
the blood test can only be performed by a laboratory
(See BOX 3).
|
|
| BOX 3: Pregnancy
tests |
In most countries, a home pregnancy
test kit is available. This is a urine test. If a woman
tests positive in a home pregnancy test, it is fairly
certain she is pregnant. If her test is negative, it may
still be too early to detect the pregnancy because
theamount of hCG in the urine is still too low. The
urine test can detect pregnancy about a week to ten days
after a woman has missed her last period [ 15].
The blood test for pregnancy is known as a beta hCG
test. This measures the exact amount of hCG in the
blood. This test is carried out in a clinical
laboratory, on being prescribed by a health provider.
The blood test can tell whether a woman is pregnant
within just one or two days after she has missed her
menstrual period [15].
A pelvic exam by a midwife or doctor can confirm
pregnancy only around six weeks after a woman’s last
menstrual period. She does not have to wait till then to
confirm pregnancy. If a woman does not want to be
pregnant, she may prefer to have a pregnancy test as
soon as she has missed her period, and make arrangements
to have an abortion.
|
|
| 12. How does a woman
find out the number of weeks she has been pregnant for
the purpose of seeking medical abortion? |
Women opting for medical abortion need to know
how many weeks pregnant they are. This is because
although dosage of mifepristone remains the same, the
dosage and number of doses of misoprostol change at
different stages of pregnancy.
The following methods
are usually used for finding out the duration of
pregnancy:
• |
Calculating the number of days that have
elapsed since the first day of the woman’s last
menstrual period. Many women make a
note of the first day of each menstrual period on a
calendar so that they can check it if needed. |
• |
Having a pelvic examination carried out
by a health provider. An experienced
provider will be able to assess the duration of
pregnancy through a pelvic examination starting from
around six weeks LMP. |
Ultrasonography may be used
if:
• |
a woman is not sure of the date
of her last menstrual period,
|
• |
she has become pregnant without resuming her
period after an abortion or a delivery, or
|
• |
there are doubts about the duration of
pregnancy even after the health provider has performed
a pelvic examination. |
With ultrasonography the size of
the gestational sac and later in pregnancy, the length
of the fetus can be measured.
|
|
| 13. How does medical
abortion compare with surgical abortion in pregnancy up
to 9 weeks? |
Medical abortion for
pregnancy ≤ 9
weeks
|
Surgical abortion
using vacuum aspiration for
pregnancy ≤ 9 weeks
|
Can be used from 4 weeks
LMP.
|
May not be available before 7
weeks LMP.
|
Resembles a natural
miscarriage.
|
Involves inserting a tube into
the uterus to aspirate the
contents.
|
Abortion usually happens at home. If misoprostol is given
in the health facility , abortion happens
there. |
Abortion happens in a health
facility.
|
Abortion process lasts more
than one day.
|
Procedure is completed within
10–15 minutes.
|
Takes at least two clinic
visits.
|
Takes one to two clinic
visits.
|
May be painful for 2-3
hours or more after using misoprostol.
|
May be painful during
aspiration and afterwards when the uterus
contracts.
|
Severe complications are
rare.
|
Severe complications are
rare.
|
Longer period of bleeding up
to several weeks, although amount of blood lost is
the same as with surgical
abortion.
|
Shorter period of bleeding, as
most blood is aspirated during the
procedure.
|
Anaesthesia is not needed.
Pain medication should be available.
|
Pain medication, light
sedation and local anaesthesia should be provided , .
|
Most effective for pregnancy
of less than 7 weeks.
|
Most effective in pregnancies
of more than 7 weeks.
|
Woman may see blood clots and
the products of
conception.
|
Woman does not see products of
conception.
|
[16]
|
|
| 14. What are the
different regimens used for medical abortion up to 9
weeks of pregnancy? |
The following regimens are recommended for
medical abortion from 4-9 weeks of pregnancy:
Oral
mifepristone and oral misoprostol
Between 4 and 7
weeks of pregnancy [4]
|
Oral
mifepristone and vaginal
misoprostol
Between 4
and 9 weeks of pregnancy [5]
|
Misoprostol alone:
vaginal or sublingual
Between 4
and 9 weeks of pregnancy [17]
|
Mifepristone: One 200 milligram
pill , taken orally,
followed by
Misoprostol: 400 micrograms (2
pills of 200 micrograms each), taken orally 24-48
hours after mifepristone . |
Between 7-9 weeks, if
bleeding does not occur within 4 hours after
administration of misoprostol, a second dose of
misoprostol 400 micrograms (2 pills of 200
micrograms each) may be inserted vaginally or
taken orally.
|
Misoprostol 800 micrograms (4
pills of 200 micrograms each), to be inserted deep
into the vagina,
Followed 3-6 hours later
by a second dose of misoprostol 800 micrograms (4
pills of 200 micrograms each), inserted
vaginally.
If abortion does not take place
within 3-6 hours after the second dose, a third
dose of 800 micrograms of misoprostol (4 pills of
200 micrograms each), can be inserted
vaginally.
If the tablets are given
sublingually, the three doses of 800 μg each are
administered at 3 hour intervals
[32]. |
|
|
| 15. What are the
different regimens used for medical abortion after 9
weeks of pregnancy? |
The dosage of mifepristone/misoprostol varies
for pregnancies of 9-13 weeks and 13-24 weeks.
The use of medical abortion after 9 weeks of
pregnancy needs to be under medical supervision in a
hospital or clinic setting because of increased risk of
complications.
The following regimens have been recommended
for medical abortion from 9–13
weeks and 13–24 weeks of
pregnancy [5]:
Oral mifepristone and vaginal
misoprostol
+ further doses of oral or
vaginal misoprostol
Between 9 and 13 weeks of
pregnancy |
Oral
mifepristone and vaginal misoprostol
+
further doses of oral
misoprostol
Between 13 and 24
weeks of pregnancy
|
Mifepristone : one 200
milligram pill, taken orally, followed
by
Misoprostol: 800 micrograms (4 pills of
200 micrograms each) to be inserted deep into the
vagina 24-48 hours after mifepristone.
Further doses of 400 micrograms (2 pills
of 200 micrograms each) of misoprostol, taken
every 3 hours orally or vaginally (depending on
the amount of bleeding) , to a maximum of
4 doses.
The woman is kept under observation in
the clinic until several hours after she
aborts.
|
Mifepristone: one 200 milligram pill,
taken orally, followed by
Misoprostol: 800 micrograms (4 pills of
200 micrograms each), to be inserted deep into the
vagina 24-48 hours after mifepristone.
Further doses of 400 micrograms of
misoprostol (2 pills of 200 micrograms each),
taken orally every 3 hours, to a maximum of 4
doses.
The woman is kept under observation in
the clinic until several hours after she
aborts. |
|
|
| 16. Can misoprostol
alone be used for abortion after 9 weeks of pregnancy? |
Misoprostol alone is sometimes used for medical
abortion in pregnancies above 9 weeks duration in places
where mifepristone is not available, but there is not
yet enough information on the safest and most effective
regimen.
Caution is needed in the use of misoprostol
alone for pregnancies above 9 weeks. The dosages of
misoprostol must be reduced as the duration of pregnancy
increases because the uterus becomes very sensitive to
prostaglandin. There is a risk of rupture of the uterus,
especially after 16 weeks of pregnancy and in women who
have a scar from a previous caesarean section [2].
|
|
| 17. How efficacious
is medical abortion? |
Efficacy of medical abortion may be measured by
rates of ongoing pregnancy. In pregnancies up to 9
weeks, only about 1% of women who use the
mifepristone/vaginal misoprostol regimen for medical
abortion have a continuing pregnancy, and in about 3-5%,
abortion is incomplete [18]. Rates of complete
abortion are lower when the mifepristone/oral
misoprostol (400 microgram) regimen is used in
pregnancies of up to 7 weeks. In one study the complete
abortion rate was 84 % when mifepristone was followed by
400 micrograms of oral misoprostol, as compared to 96%
with mifepristone and 800 micrograms of vaginal
misoprostol [19].
Efficacy depends on the length of pregnancy:
the more advanced the pregnancy, the lower the complete
abortion rate and the higher the rate of ongoing
pregnancy. For example, in one large study on use of
medical abortion during 9-13 weeks of pregnancy (with
the dosages mentioned under Q.13), 96% of the women
experienced complete abortion [20]. About 5% may have an
ongoing pregnancy with medical abortion at 13-20 weeks
of pregnancy [18].
The success rate with misoprostol alone is
lower and more variable. Efficacy rates range from
10–15% ongoing pregnancies for
pregnancies up to 9 weeks duration [21]. Evidence is not yet
unavailable on efficacy rates for pregnancies above 9
weeks duration.
|
|
| 18. How long does it
take to terminate a pregnancy with medical abortion? |
When a mifepristone/misoprostol regimen is used
for medical abortion in pregnancy up to 9 weeks, in a
few instances (2-3% of women), a woman may abort after
taking the mifepristone and before using misoprostol. Of
the rest, about 90% will have a complete abortion within
4-6 hours of using misoprostol [5].
After nine weeks of pregnancy, the more
advanced the pregnancy, the longer it takes to have a
complete abortion [18] [20].
In one study, the time taken for complete abortion was
about six hours for women with previous deliveries and
about 8 hours for women with no previous deliveries.
More than 70% of the women went home the same day [22].
There is a lot of variability in the reported
time needed for abortion with misoprostol alone up to 9
weeks of pregnancy, depending on the duration of
pregnancy, dosage and route of administration. One study
reported that 72% and 86% of women aborted within 24
hours of one and two doses respectively of 800
micrograms of vaginal misoprostol [23].
|
|
| 19. How many clinic
visits are required for a medical abortion? What is done
during each visit? |
Studies show that two clinic visits are
adequate to ensure safe use of mifepristone/misoprostol
for pregnancies up to 9 weeks, and three clinic visits
are needed for pregnancies of more than 9 weeks’
duration.
When mifepristone/misoprostol
combination is used
Up to 9 weeks of
pregnancy
First
visit
The health provider
• |
|
• |
takes medical history to ensure that she
does not suffer from any of the medical conditions
that would make medical abortion inappropriate for her
|
• |
asks the woman when the first day of her
last period was and performs a pelvic exam to
determine or confirm duration of pregnancy and absence
of genital infection (if infection is present, it is
treated) |
• |
may perform an ultrasound if duration of
pregnancy cannot be accurately assessed through
medical history and pelvic exam |
• |
gives her mifepristone to be taken
orally |
• |
gives her the choice of either taking
misoprostol at home, or coming back to the clinic for
taking misoprostol under medical supervision. |
If the woman opts to
take the misoprostol at home, then the
provider
• |
gives her  the 800
microgram dose of misoprostol (4 pills of 200
micrograms each) to be inserted vaginally, or 400
microgram dose of misoprostol (2 pills of 200
micrograms each) to be taken orally at home, 24-48
hours after mifepristone.
|
• |
gives a pain-killer to help cope with the
cramps and pain that the woman will experience once
she has taken misoprostol.
|
Second visit (if the woman opts to
take misoprostol in the clinic)
This visit should be between 24 and 48 hours
after the first visit [4]. During this visit,
misoprostol is inserted vaginally (in pregnancies up to
nine weeks) or taken orally (in pregnancies up to seven
weeks).
In many settings, the woman is kept under
observation in the clinic for 4-6 hours. During this
time, more than 90 per cent of women will have expelled
the products of conception [5].
If abortion does not occur within the
observation period, the woman may be permitted to go
home to abort.
In a few places, misoprostol may be
administered by a provider and the woman can leave
immediately. In this case, the woman needs to know that
abortion may occur before she reaches home.
Follow-up visit
All women are asked to return 14 days after
they took mifepristone. This is to check if abortion is
complete and that all products of conception have been
expelled.
During this visit, the health
provider:
• |
carries out a physical examination to
confirm that the pregnancy has been terminated
|
• |
if in doubt after the physical exam,
performs a pregnancy test or an ultrasound exam to
confirm termination of pregnancy
|
• |
if abortion is not complete, either asks the
woman to come back after a few more days, as the
abortion may be complete by then, or administers
further misoprostol, or performs a surgical procedure
to complete the abortion.
|
Pregnancies of more than 9 weeks
duration
In this case, the only difference is that there
are at least three clinic visits. The woman
returns to the clinic24-48 hours days after her first
visit, when she took mifepristone. Misoprostol is
administered by a health provider in a clinic
setting.
During this visit, misoprostol is inserted
vaginally, followed by several additional doses of the
drug vaginally and/or orally until abortion takes place.
The woman is kept under observation until several hours
after she expels the products of conception.
This is followed by a follow-up visit, as
described above.
When misoprostol alone is used
In pregnancies of less than 9 weeks
duration, the dosage regimen consists of repeated doses
of vaginal or sublingually misoprostol till
abortion occurs. This may mean staying in the health
facility for at least a day, or administering repeat
doses of misoprostol at home, depending on the
setting.
|
|
| 20. Can mifepristone
and misoprostol be taken at home in a
mifepristone/misoprostol regimen? |
In pregnancies of up to 9 weeks, there is no
reason why home use of mifepristone and misoprostol should be unsafe, provided the woman
has accurate information about who can and cannot take
the drug, the dosage for different regimens, side
effects and complications, and has access to medical
care if needed. Home use of mifepristone/misoprostol is
not recommended after 9 weeks of pregnancy, when it is
important to use medical abortion under the supervision
of a competent medical professional.
|
|
| 21. What is the
experience of medical abortion like? |
Women who use medical abortion will experience
menstrual-like cramps, pain in the abdomen and bleeding.
For most women, uterine cramps and vaginal bleeding
start between one hour and seven hours after they
take misoprostol. But some 5% of women will start to
have cramps already after they take
mifepristone.
Vaginal bleeding is heavier than menstruation
while abortion is occurring and the products of
conception are being expelled. This heavy bleeding lasts
only for a short duration, about 1-4 hours. Light
bleeding and spotting will continue for 9-13 days. In
rare cases, women may experience light bleeding for up
to 45 days after the abortion occurs [4]. The amount of
bleeding depends on the duration of pregnancy and the
drug used.
Many women compare the process to a spontaneous
miscarriage. Women may also notice passing blood clots,
tissue or products of conception [24].
Women may experience other side effects such as
diarrhoea, nausea, vomiting, headache, dizziness, back
pain and tiredness. These side effects occur after
misoprostol administration but last only for about 2-4
hours. Several studies show that nausea, vomiting and
diarrhoea with vaginally administered misoprostol are
fewer as compared to taking misoprostol orally [24].
|
|
| 22. What are some
common side effects of medical abortion, and what can a
woman do to manage these? |
Bleeding
• |
A small number of women develop bleeding
after mifepristone alone. It is a good idea to go
prepared with sanitary pads (bought from the shops or
home-made).
|
• |
In settings that require women to return to
the health facility to take misoprostol, again, the
woman should go prepared with sanitary pads in case
she develops bleeding before returning home.
|
• |
It is possible that some women cannot afford
to buy sanitary pads from the pharmacy to last for the
entire duration of bleeding. It is important for a
woman to wash and sun-dry home-made sanitary pads and
make sure that she changes pads as soon as they get
soaked and she begins to feel discomfort because of
the wetness. |
Pain
• |
Cramps and pain experienced by women are
variable. Between a third and two-thirds of women
experience only mild pain and do not even need an
analgesic. Others may experience cramps that are
comparable to severe menstrual cramps.
|
• |
It may be good for the woman to be
accompanied to the health facility by someone who can
help if the woman has to travel back home on foot or
by public transport, in case she develops severe pain
and cramps.
|
• |
When at home, the woman may lie
down or sit comfortably to relieve pain. She may try
to relax by listening to music, watching television,
talking to friends/family members, taking a warm
shower, or using a hot water bottle or heating pad on
her abdomen for pain relief [ 11].
|
• |
The woman may have been given pills for pain
relief by the health provider on her first or second
visit to the clinic. These may be taken as instructed.
If no painkillers have been prescribed, she can take
one available without prescription, such as
Paracetamol. |
Nausea, vomiting and
diarrhoea
• |
Eating a light diet and consuming plenty of
fluids will help if nausea, vomiting or diarrhoea
develops. If these symptoms become severe, and a woman
is unable to keep any food in, she should contact her
health provider for medication to control vomiting and
diarrhoea [ 11].
|
• |
If the woman vomits within half an hour of
taking an oral dose of misoprostol, she has to take a
repeat dose of the drug.
|
Consumption
of a lcohol and
drugs
• |
Alcohol and narcotic drugs should not be
taken when mifepristone/misoprostol have been taken,
at least till the completion of abortion [ 24].
|
It is important to consult the health provider
if you are taking any other prescription or
non-prescription drugs or herbal medicines or
preparations when seeking medical abortion. These drugs
or preparations may interfere with the action of
mifepristone [25].
|
|
| 23. What are some
complications of medical abortion, and what can be done
about these? |
Heavy or excessive
bleeding
If abortion is incomplete, there is a risk of
heavy bleeding. Some health providers treat heavy
bleeding with a drug called Methergin before performing
a surgical abortion. Approximately 1% of women using
medical abortion up to 9 weeks of pregnancy require this
[11].
In rare instances, the woman may experience
excessive uterine bleeding. Such heavy bleeding usually
occurs 1-3 weeks after taking the medications (apart
from the bleeding after taking misoprostol).
A woman will know that bleeding is too heavy if
• |
two thick sanitary pads get soaked with
blood within 1 hour, and
|
• |
this happens 2 hours in a row, i.e. she has
to use four pads in two hours
|
About 1 in 1000 women experience bleeding that
is so heavy that they need a blood transfusion [16].
A woman should contact her health provider
without delay if she has such heavy bleeding. In the
meanwhile, she should drink a lot of fluids so that she
does not lose essential minerals from her body.
Infection
Chills and a mild rise in temperature usually
occur immediately after misoprostol has been taken.
These are side effects of the medication, not signs of
infection, and usually last only for about 2 hours [11].
Less than 1% of women have been shown to
develop infection after medical abortion [26]. Infection may be
suspected if
• |
a woman develops a fever above
100.4o F (38.0o C) that lasts
for more than 4 hours, or
|
• |
if fever starts 6 to 8 hours after she has
taken misoprostol.
|
The woman needs medical help if she develops
these symptoms [11]. She may be treated
as an outpatient and sent home, or may need to be
admitted to hospital as an inpatient for treatment,
depending on the severity of the infection and the need
for observation and further tests.
|
|
| 24. How safe is
medical abortion? |
Four deaths following medical abortion in the
United States and one in Canada, which occurred between
2001 and 2005, were the subject of recent articles and
letters in the medical and mainstream media. These were
associated with infection from an anaerobic bacterium
called Clostridium sordellii; they were not
attributed to the medical abortion drugs. In March 2006,
two additional deaths were reported in the United States
following medical abortion. One of these
deaths has features consistent with Clostridium
sordellii; the other appears not to have been
related to the abortion at all.
Clostridium sordellii is a spore found
in soil. How and why it is involved in these deaths is
not yet understood. Research on the reasons
why these deaths occurred has begun and what to do to
prevent them, and an expert meeting will be held in the
United States in May 2006 to review existing data.
However, in none of these deaths is there evidence
suggesting that the use of mifepristone or misoprostol
was implicated as the cause of infection.
Fatal infections from Clostridium sordellii have been
known to occur in women following childbirth and
miscarriage as well. These infections, as well as those
occurring after medical abortion, are extremely rare. It
has been standard practice in the United States, Sweden,
the UK and in many other countries to
administer misoprostol vaginally. In other
countries, misoprostol has typically been administered
orally. Again, there is no evidence to suggest that the
route of administration of misoprostol is related to
infection from Clostridium
sordellii.
Moreover, no deaths from Clostridium sordellii infection have been reported among the more than
three million women outside of the United States who
have used medical abortion to date.
In China, where more than 22 million women
have used medical abortion, there have been no reports
of this infection either, though data are limited.
Abortion is one of the safest medical
procedures. It is important to remember that the risk of
complications is extremely low when the abortion is
carried out with a trained provider. The ICMA Steering
Committee, along with everyone working in the field, is
concerned about these deaths. However, we continue to
support the use of medical abortion, based
on its excellent safety record. We are
closely monitoring further developments and will
continue to make any new information available on the
ICMA website [33], [34],
[35], [36].
|
|
| 25. How would a woman
know if the pregnancy has not been terminated? |
A woman may suspect that the pregnancy is
ongoing if
• |
there is no or only slight bleeding after
taking the drugs for medical abortion
|
• |
she continues to experience symptoms of
pregnancy.
|
When taken under medical supervision, a woman
is always asked to return for a follow-up visit within
14 days from the day she took mifepristone. The health
provider will confirm whether abortion has occurred and
whether further treatment is needed. If there is reason
to suspect that pregnancy is ongoing, or that abortion
is incomplete, a beta hCG blood test may be done and/or
an ultrasound exam.
It is important that she consults a health
provider. If pregnancy is ongoing, the health provider
may give a further dose of misoprostol. If the woman
wishes to have the pregnancy terminated right away, her
health provider should arrange for a surgical abortion
as soon as possible.
|
|
| 26. Is there a
concern about birth defects in case pregnancy is not
terminated? |
In the vast majority of pregnancies carried to
term after use of mifepristone/misoprostol or
misoprostol alone, the infant born will be normal.
However, a small number of studies to examine
the risk of birth defects have concluded that there may
be a slightly higher risk of birth defects in infants
born after use of misoprostol. The majority of these
defects pertain to the central nervous system and lower
and upper limbs [21]. Mifepristone does
not cause birth defects [4].
|
|
| 27. How long after
having a medical abortion can women resume sexual
intercourse? |
After having medical abortion a woman should
not engage in vaginal sex or insert anything into her
vagina for about one week after the drugs have been
taken [3], or until she feels
ready.
|
|
| 28. How long after
having a medical abortion can a woman become pregnant? |
If she does not use an effective method of
contraception, a woman can become pregnant before her
first period. Conception can occur within 10 days to two
weeks of having a medical abortion, depending on the
length of her menstrual cycle [3].
|
|
| 29. How long after a
medical abortion will a woman resume normal
menstruation? |
A woman can expect to have normal menstruation
within about four to six weeks after medical abortion,
provided she has not become pregnant again [3].
|
|
| 30. When can a woman
start using contraception after medical abortion? |
A woman can start using contraception on the
day of taking misoprostol. Suitable methods are: oral
pill, hormonal injectables and implants. Barrier methods
of contraception such as the condom, contraceptive
jellies and foams, cervical cap and the diaphragm can be
used when sexual intercourse is resumed. If a woman
wants to have an intra-uterine device (IUD) inserted,
she will have to wait till the abortion is complete and
all products of conception have been expelled [11].
As for sterilization after medical abortion,
there are no restrictions or contraindications, and the
procedure may be carried out any time after the
abortion, i.e. expulsion of products of conception. In
practice, however, women who plan to have sterilization
may prefer surgical abortion, so that both procedures
can be done under the same anaesthesia.
|
|
| 31. Does medical
abortion have long-term effects on a woman's health? |
Medical abortion has no known long-term
negative effects on a woman’s health. It may contribute
positively to her well-being by removing the stress of
unwanted pregnancy [11].
|
|
| 32. Will medical
abortion affect a woman's ability to have a child in the
future? |
Medical abortion will not affect a woman’s
ability to become pregnant and have a child in future
[11]. One study from China
that has looked at women’s subsequent wanted pregnancies
and their outcomes after one medical abortion found no
adverse effects on the outcome [30]. Es
más, un estudio reciente publicado en el New England
Journal of Medicine, no encontró efectos adversos sobre
la fertilidad o los embarazos subsiguientes. [38]
|
|
| 33. Are there adverse
effects associated with having more than one medical
abortion? |
There have been no long-term studies that have
investigated this issue.
|
|
| 34. How expensive is
medical abortion? |
Costs of medical abortion vary widely across
countries depending on:
• |
|
• |
|
• |
dosages (number of pills) of mifepristone
and misoprostol used |
• |
cost of clinic consultations |
• |
cost of pregnancy testing |
• |
cost of ultrasound (if used). |
There may be additional costs if surgical
aspiration is needed to complete the abortion and if
additional visits are necessary for treating
complications.
However, the cost of mifepristone currently
forms the major component of the cost of medical
abortion everywhere in the world.
The retail prices of mifepristone in different
countries as of 2005 were as follows [31]:
• |
|
: |
US$ 250 (600 mg) |
• |
|
: |
US$130-140 (600
mg) |
• |
UK |
: |
US $ 75 (600 mg) |
• |
China, India,
Vietnam |
: |
US $ 6-8 (200 mg) |
Retail Misoprostol is affordable in almost all
settings, though a woman using misoprostol alone will
probably need a greater number of pills. For example, 1
tablet of 200 micrograms of Misoprostol costs US$0.30 in
the UK when accessed from hospitals and licensed
facilities providing medical abortion, and about US$
0.50 South Africa [31].
The actual cost to women of a medical abortion
also depends on how abortion services are paid for, and
whether medical abortion is covered by public financing
or insurance.
|
|
| 35. In which
countries can women obtain a medical abortion using
mifepristone/misoprostol? In which countries is
misoprostol available? |
For details of the list of the countries where
mifepristone is licensed and a map of countries where
misoprostol is approved, log on to www.gynuity.org/pub_b.html#q6.
|
|
| 36. What options do
women have in countries where abortion is legally
restricted? |
Every woman should have the right to terminate
an unwanted pregnancy safely. There are many reasons why
a woman may want to terminate a pregnancy. Pregnancy may
be the result of sexual assault or non-consensual sex; a
woman may no longer want to continue with a pregnancy
because her circumstances have altered since she became
pregnant; social and economic circumstances may not
allow her to continue the pregnancy; there may have been
contraceptive failure; the woman may not have access to
an effective method of contraception, or did not have
information on how to prevent pregnancy.
Unfortunately, abortion is legally restricted
in many countries. Because safe abortion services are
not available, many women attempt to do an abortion by
inserting sharp objects or herbal medicines into the
uterus, or by putting pressure on the belly or by
drinking herbal concoctions. In many instances, these
can cause serious morbidity or even death.
In most countries where abortion is legally
restricted it is unlikely that mifepristone will be
registered. But misoprostol is widely available in
almost all countries since it is registered for
treatment of gastric ulcer.
Use of misoprostol bought over the counter from
pharmacies is widespread in Latin America and the
Caribbean and in a growing number of Asian countries.
Experience from countries such as Brazil and Chile has
shown that medical abortion is safer than the invasive
alternatives that women were forced to use to induce an
abortion. Although there are side effects, these can
almost always be managed with simple medications [2].
Reporting to a health facility after home-use
of misoprostol to complete the abortion will facilitate
timely management of any potential complications.
Misoprostol offers women living in countries with legal
restrictions on abortion with an important alternative
to abortion methods that are
always dangerous.
See Women on Web as a possible
alternative.
|
|
| References |
[1] |
Winikoff B. Global overview of medical
abortion. Presentation at Medical Abortion: An
International Forum on Policies, Programmes and
Services, 17-20 October 2004, Johannesburg. |
[2] |
Shannon CS, Winikoff B. (editors). Misoprostol:
An emerging technology for women’s health. Report of a
seminar. New York, Population Council, 2004. |
[3] |
www.medicalabortion.org/questions/work.html,
referred on 25 May 2005 |
[4] |
World Health Organization. Safe abortion:
Technical and policy guidelines for health systems.
Geneva, WHO, 2003. |
[5] |
Royal College of Obstetricians and
Gynaecologists. The Care of Women Requesting Induced
Abortion. National Evidence-Based Clinical Guidelines.
London: RCOG, September 2004. Summary at:
<www.rcog.org.uk/resources/
Public/pdf/abortion_summary.pdf>. Accessed 27 October
2005. |
[6] |
Mifiprex (mifepristone) medication guide.
www.fda.gov/cder/drug/
infopage/mifepristone/medguide.htm. Referred on 15 June,
2005. |
[7] |
Information on ectopic pregnancy from
http://www.medicinenet.com/ectopic_pregnancy/article.htm.
Referred on 10 June, 2005. |
[8] |
Hill NC, Selinger M, Ferguson J et al. The
placental transfer of mifepristone during the second
trimester and its influence upon maternal and fetal
steroid concentrations. British Journal of Obstetrics
and Gynaecology, 1990, 97:406-411. |
[9] |
Vogel D, Burkhardt T, Rentsch K et al.
Misoprostol versus methylergometrine: pharmacokinetics
in human milk. American Journal of Obstetrics and
Gynecology, 2004, 191:2168-2173. |
[10] |
De Bruyn M. Safe abortion for HIV-positive
women with unwanted pregnancy: A reproductive right.
Reproductive Health Matters, 2003; Vol.11 No. 22: 52-61. |
[11] |
Gynuity. Providing medical abortion in
developing countries: An introductory guidebook. New
York, Gynuity Health Projects, 2004. |
[12] |
Berer M. Medical abortion: Issues of choice
and acceptability. Reproductive Health Matters
2005;13(26):25-34): |
[13] |
Ganatra B. Contrasts and Common Ground: The
Context of Abortion in Asia. Presentation at Medical
Abortion: An International Forum on Policies, Programmes
and Services, 17-20 October 2004, Johannesburg, South
Africa |
[14] |
Elul B, Peralman E, Sorhaindo A, et al.
In-depth interviews with medical abortion clients:
Thoughts on the method and home administration of
Misoprostol. Journal of the American Medical Women’s
Association Volume 55, no. 3 supplement 2000 pp 169-172. |
[15] |
Information on pregnancy tests from
www.4woman.gov/faq/pregtest.htm, referred on 10 June,
2005. |
[16] |
www.medicationabortion.org/questions/index.html referred
on 15 May, 2005 with inputs from ICMA Steering Committee
members and reviewers. |
[17] |
von Hertzen H, Nguyen H, Piaggio G, et al.
Comparison of two routes and two intervals of
administration of misoprostol for the termination of
early pregnancy: a randomised multicentre trial. Interim
results (unpublished) |
[18] |
Clinical Guidelines: medical abortion 13–20
weeks. London: bpas, 2005. |
[19] |
Schaff EA, Fielding SL, Westhoff C. Randomized
trial of oral versus vaginal misoprostol 2 days after
mifepristone 200mg for abortion up to 63 days of
pregnancy. Contraception 2002;66:247-50 |
[20] |
Hamoda H, Ashok PW, Flett G, et al. Medical
abortion at 9–13 weeks' gestation: a review of 1,076
consecutive cases. Contraception 2005;71:327–32. |
[21] |
Consensus Statement: Instructions for use –
Abortion induction with misoprostol in pregnancies up to
9 weeks LMP. Expert Meeting on misoprostol sponsored by
Reproductive Health Technologies Project and Gynuity
Health Projects. July 28, 2003, Washington D.C. |
[22] |
Fiala C, Swahn ML, Stephansson O, et al. The
effect of non-steroidal anti-inflammatory drugs on
medical abortion with mifepristone and misoprostol at
13-22 weeks gestation. Human Reproduction 2005;Aug 11
(Abstract only, e-publication). |
[23] |
Jain JK, Dutton C, Harwood B et al. A
prospective randomized, double-blinded,
placebo-controlled trial comparing mifepristone and
vaginal misoprostol to vaginal misoprostol alone for
elective termination of early pregnancy. Human
Reproduction 2005;17(6):1477-1482. |
[24] |
www.ppnyc.org/services/factsheets/mifep.htm referred on 2 June, 2005. |
[25] |
US Food and Drug Administration. FDA Alert for
Healthcare Professionals: Mifepristone (marketed as
Mifeprex), 22 July 2005. At:
<http://www.fda.gov/cder/drug/InfoSheets/HCP/MifepristoneHCP.pdf>
and
<http://www.fda.gov/cder/drug/infopage/mifepristone/mifepristone-qa20050719.htm>.
Accessed 29 August 2005. |
[26] |
Shannon C, Brothers LP, Philip NM, et al.
Infection after medical abortion: a review of the
literature. Contraception 2004;70:183–90. |
[27] |
Fischer M, Bhatnagar J, Guarner J et al. Fatal
toxic shock syndrome associated with clostridium
sordellii after medical abortion. New England Journal of
Medicine 2005;353: 23522360. |
[28] |
Greene MF. Fatal infections associated with
mifepristone-induced abortion. New England Journal of
Medicine 2005;353: 23172318. |
[29] |
Grimes DA. Risk of mifepristone in context
[Commentary]. Contraception 2005;71:161. |
[30] |
Chen A, Yuan W, Meirik O et al.
Mifepristone-induced early abortion and outcome of
subsequent wanted pregnancy. American Journal of
Epidemiology 2004;160(2):110-117. |
[31] |
www.gynuity.org/pub_b.html#q6, referred on 7
February 2006. |
[32] |
Von Hertzen H, Piaggio G, Nguyen Thi My Huong,
et al. Efficacy of two intervals and two routes of
administration of misoprostol for termination of early
pregnancy: a randomized controlled equivalence trial.
Lancet 2007;369:1938-46. |
[33] |
US Food and Drug Administration. FDA Public
Health Advisory Sepsis and Medical Abortion Update 17
March 2006. At:
http://www.fda.gov/cder/drug/advisory/mifeprex200603.htm |
[34] |
US Food and Drug Administration. FDA Alert for
Healthcare Professionals: Mifepristone (marketed as
Mifeprex), 22 July 2005. At:
www.fda.gov/cder/drug/InfoSheets/HCP/MifepristoneHCP.pdf and
www.fda.gov/cder/drug/infopage/mifepristone/mifepristone-qa20050719.htm |
[35] |
Fischer M et al. Fatal toxic shock syndrome
associated with clostridium sordellii after medical
abortion. New England Journal of Medicine
2005;353:23522360. |
[36] |
Greene MF. Fatal infections associated with
mifepristone-induced abortion. New England Journal of
Medicine 2005;353:23172318. |
[37] |
Grimes DA. Risk of mifepristone in context
[Commentary]. Contraception 2005;71:161 |
[38] |
Jasveer Virk, M.S., M.P.H., Jun Zhang, Ph.D.,
M.D., and Jørn Olsen, M.D., Ph.D.Medical Abortion and
the Risk of Subsequent Adverse Pregnancy Outcomes. New
England Journal of Medicine, Volume 357:648-653, August
16,2007, Number 7 |
|
|